v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   48,051        
Beginning balance at Dec. 31, 2022 $ 1,031,569 $ 48 $ 1,325,524 $ (295,117) $ 1,370 $ (256)
Beginning balance (in shares) at Dec. 31, 2022           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   91        
Exercise of options to purchase common stock 3,061   3,061      
Vesting of restricted stock units (in shares)   43       0
Vesting of restricted stock units (850) $ 0 (850)      
Share-based compensation expense 13,986   13,986      
Purchase of capped call options (66,211)   (66,211)      
Foreign currency translation (2,033)       (2,033)  
Net loss (41,738)     (41,738)    
Ending balance (in shares) at Jun. 30, 2023   48,185        
Ending balance at Jun. 30, 2023 937,784 $ 48 1,275,510 (336,855) (663) $ (256)
Ending balance (in shares) at Jun. 30, 2023           14
Beginning balance (in shares) at Mar. 31, 2023   48,109        
Beginning balance at Mar. 31, 2023 948,907 $ 48 1,267,642 (319,903) 1,376 $ (256)
Beginning balance (in shares) at Mar. 31, 2023           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   56        
Exercise of options to purchase common stock 1,107   1,107      
Vesting of restricted stock units (in shares)   20        
Vesting of restricted stock units (248)   (248)      
Share-based compensation expense 7,009   7,009      
Foreign currency translation (2,039)       (2,039)  
Net loss (16,952)     (16,952)    
Ending balance (in shares) at Jun. 30, 2023   48,185        
Ending balance at Jun. 30, 2023 $ 937,784 $ 48 1,275,510 (336,855) (663) $ (256)
Ending balance (in shares) at Jun. 30, 2023           14
Beginning balance (in shares) at Dec. 31, 2023 48,263 48,277        
Beginning balance at Dec. 31, 2023 $ 953,454 $ 48 1,282,984 (328,731) (591) $ (256)
Beginning balance (in shares) at Dec. 31, 2023 14         14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares) 145 145        
Exercise of options to purchase common stock $ 4,196   4,196      
Vesting of restricted stock units (in shares)   71       0
Vesting of restricted stock units (2,159)   (2,159)      
Share-based compensation expense 23,602   23,602      
Foreign currency translation (197)       (197)  
Net loss $ 16,908     16,908    
Ending balance (in shares) at Jun. 30, 2024 48,479 48,493        
Ending balance at Jun. 30, 2024 $ 995,804 $ 48 1,308,623 (311,823) (788) $ (256)
Ending balance (in shares) at Jun. 30, 2024 14         14
Beginning balance (in shares) at Mar. 31, 2024   48,449        
Beginning balance at Mar. 31, 2024 $ 977,844 $ 48 1,288,890 (310,129) (709) $ (256)
Beginning balance (in shares) at Mar. 31, 2024           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   40        
Exercise of options to purchase common stock 1,381   1,381      
Vesting of restricted stock units (in shares)   4       0
Vesting of restricted stock units (77)   (77)      
Share-based compensation expense 18,429   18,429      
Foreign currency translation (79)       (79)  
Net loss $ (1,694)     (1,694)    
Ending balance (in shares) at Jun. 30, 2024 48,479 48,493        
Ending balance at Jun. 30, 2024 $ 995,804 $ 48 $ 1,308,623 $ (311,823) $ (788) $ (256)
Ending balance (in shares) at Jun. 30, 2024 14         14